Sa US, ang drug labeling ay hindi isang design choice — ito ay isang legal na obligasyon na tinukoy ng federal law at FDA regulations. Ang mga produktong may hindi tamang label ay maaaring tanggihan sa US border o i-recall mula sa merkado.
OTC Drugs: Drug Facts Panel
Ang mga OTC drug product ay kailangang magkaroon ng Drug Facts Panel ayon sa 21 CFR 201.66. Ang panel ay dapat maglaman ng active ingredients, indications, warnings, directions, inactive ingredients, at manufacturer information sa tamang pagkakasunod-sunod at format.
Sinusuportahan ng FDABridge ang Labeling Compliance
Nagsasagawa ang FDABridge ng drug labeling review bago ang shipment. Bisitahin ang fdabridge.com/drug.
ต้องการความช่วยเหลือในขั้นตอนถัดไป?
ต้องการความช่วยเหลือในการเลือกบริการหรือไม่?
เปรียบเทียบตัวเลือกหลักและเลือกขั้นตอนที่เหมาะกับผลิตภัณฑ์ของคุณ